Original Research ARTICLE
Moderate Exercise Allows for shorter Recovery Time in Critical Limb Ischemia
- 1Université de Strasbourg, Fédération de Médecine Translationnnelle, Equipe d'Accueil 3072, Mitochondrie, Stress Oxydant et Protection Musculaire, Institut de Physiologie, Strasbourg, France
- 2Service de Physiologie et Explorations Fonctionnelles Respiratoires, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
- 3Service de Chirurgie Vasculaire et Transplantation Rénale, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
- 4Institut de Génétique et Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique UMR7104/Institut National de la Santé et de la Recherche Médicale U964, Université de Strasbourg, Strasbourg, France
- 5Faculté des Sciences du Sport, Université de Strasbourg, Strasbourg, France
- 6Unité Neurovasculaire, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
Whether and how moderate exercise might allow for accelerated limb recovery in chronic critical limb ischemia (CLI) remains to be determined. Chronic CLI was surgically induced in mice, and the effect of moderate exercise (training five times per week over a 3-week period) was investigated. Tissue damages and functional scores were assessed on the 4th, 6th, 10th, 20th, and 30th day after surgery. Mice were sacrificed 48 h after the last exercise session in order to assess muscle structure, mitochondrial respiration, calcium retention capacity, oxidative stress and transcript levels of genes encoding proteins controlling mitochondrial functions (PGC1α, PGC1β, NRF1) and anti-oxidant defenses markers (SOD1, SOD2, catalase). CLI resulted in tissue damages and impaired functional scores. Mitochondrial respiration and calcium retention capacity were decreased in the ischemic limb of the non-exercised group (Vmax = 7.11 ± 1.14 vs. 9.86 ± 0.86 mmol 02/min/g dw, p < 0.001; CRC = 7.01 ± 0.97 vs. 11.96 ± 0.92 microM/mg dw, p < 0.001, respectively). Moderate exercise reduced tissue damages, improved functional scores, and restored mitochondrial respiration and calcium retention capacity in the ischemic limb (Vmax = 9.75 ± 1.00 vs. 9.82 ± 0.68 mmol 02/min/g dw; CRC = 11.36 ± 1.33 vs. 12.01 ± 1.24 microM/mg dw, respectively). Exercise also enhanced the transcript levels of PGC1α, PGC1β, NRF1, as well as SOD1, SOD2, and catalase. Moderate exercise restores mitochondrial respiration and calcium retention capacity, and it has beneficial functional effects in chronic CLI, likely by stimulating reactive oxygen species-induced biogenesis and anti-oxidant defenses. These data support further development of exercise therapy even in advanced peripheral arterial disease.
Peripheral arterial disease (PAD) is linked to stenosis or occlusion of the arteries that are responsible for decreased perfusion of the lower limbs. PAD symptoms range from intermittent claudication (defined by muscle pain on walking) to critical limb ischemia (CLI; characterized by rest pain or ulcers; Norgren et al., 2007). The clinical and economical impacts of PAD are large, since expensive vascular surgical procedures with high rates of hospitalizations and repeated interventions are required, especially in CLI (Norgren et al., 2007; Mahoney et al., 2010; Shishehbor et al., 2016).
Recently major advances have been observed in the knowledge of PAD pathophysiology (Charles et al., 2017). Notably, interactions between muscle mitochondria and reactive oxygen species (ROS) have been emphasized (Lejay et al., 2014). Oxidative stress, which precedes mitochondrial dysfunction, arises during ischemia, and is enhanced after reperfusion (Guillot et al., 2014). This suggests that modulating ROS production may reduce ischemia-reperfusion injury. Accordingly, mitochondrial function is protected when ROS production is reduced and/or when the production of ROS can be efficiently handled by the antioxidant system (Lejay et al., 2014; Charles et al., 2017). However, interactions between mitochondria and ROS are subtle. Significant increases in ROS production are generally considered to be deleterious because it induces lipid peroxidation, protein carbonylation, and mitochondrial dysfunction that in turn is associated with reduced ATP production (Lejay et al., 2014). Conversely, a slight increase of ROS can act as a signaling pathway that stimulates mitochondrial biogenesis and enhances antioxidant defenses (Charles et al., 2017). Mitochondria are thus largely involved in PAD pathophysiology and they are now considered as a therapeutic target in CLI (Ryan et al., 2015; Paradis et al., 2016).
Exercise therapy represents an effective non-pharmacologic treatment for PAD patients suffering from intermittent claudication by improving walking ability and providing protective effects against mortality in these patients (Gardner et al., 2008; Leeper et al., 2013; Conte and Pomposelli, 2015; Gardner, 2015; Baum et al., 2016; Gouspillou and Hepple, 2016; Whayne and Mukherjee, 2016). Exercise ability also provides prognostic information beyond traditional risk factor assessment since low exercise capacity is strongly related to the risk of mortality in these patients (Parmenter et al., 2015). However, since CLI is an advanced stage of PAD, high intensity-training protocols performed in the setting of intermittent claudication cannot be used (Abe et al., 2012; Lejay et al., 2014; Conte and Pomposelli, 2015). We hypothesized therefore that moderate exercise should be tested in CLI.
We investigated the effects of a specific moderate-intensity exercise-training protocol on CLI symptoms, using our established CLI murine model that mimicks the human pathology (Lejay et al., 2015). Further, since mechanisms involved in the potential beneficial effects of exercise include oxidative stress modulation (Rokutanda et al., 2011; Hoier et al., 2013; Muller et al., 2013; Nunomiya et al., 2016), we have tested the hypothesis that, in this protocol, functional benefits might be linked to restored mitochondrial function and calcium retention capacities which are in turn restored, through of ROS-induced biogenesis and anti-oxidant defenses.
Materials and Methods
The study was approved by the CREMEAS ethical committee (AL/70/77/02/13). French laws for animal use and care were respected. Twenty Swiss mice (male, 8 weeks old, weighting 30–35 grams) were handled. Surgery was performed under general anesthesia and post-operative analgesia was obtained using buprenorphine (Buprecare®, Animal care).
Critical Limb Ischemia Model
General anesthesia was conducted in an airtight ventilated chamber (3% isoflurane (Aerrane®, Baxter Healthcare) and air) and anesthesia maintenance was obtained by spontaneous ventilation through a mask (2% isoflurane, air).
The surgery included two phases. First, the right femoral artery and its first three collateral vessels were ligated under microscope. Ligation of the femoral artery was standardized. It was located midway between the superficial epigastric artery and the bifurcation of the popliteal and saphenous arteries. Second, the right common iliac artery was ligated 0.5 cm distal to its origin, 4 days after the first phase, as described in our established CLI model (Lejay et al., 2015). In this model, the right limb suffers from CLI while the left limb can be considered as control (Thaveau et al., 2007, 2009).
Animals were divided into two groups, one group to be sacrificed 30 days after surgery (Non-exercised group, n = 10); and one group to be subjected to exercise and sacrificed 30 days after surgery (Exercised group, n = 10).
The exercised group was trained over a 3-week period, five times per week, starting at Day 7 (when CLI was effective). Exercise was performed on a motorized treadmill (Treadmill Control, Letica, Spain). Each session was preceded by a warm-up phase of 2 min (10° incline, 15 cm/s). During Week 1, animals run in the treadmill with a 10° inclination and a belt speed set at 25 cm/s. Length of exercise was 30 min for Day 1 and Day 2, 45 min for Day 3 and 60 min for Day 4 and Day 5. During Week 2, the inclination remains at 10° but the belt speed was set at 30 cm/s. Length of exercise was 60 min for Day 1 and Day 2, 75 min for Day 3 and Day 4 and 90 min for Day 5. During Week 3, animals run for 90 min with the treadmill set at 10° 30 cm/s for Days 1–5. Animals were sacrificed at Day 30 (48 h after the last exercise session).
In vivo Clinical Follow-Up
In vivo clinical follow-up was assessed using already-established clinical scores (Stabile et al., 2003). Tissue damage was graded attributing 1 for a normal aspect of the limb, 2 for a white aspect, 3 for toe cyanosis, 4 for necrosis, and 5 for spontaneous amputation of a toe. Functional score was graded attributing 0 for a normal function of the limb, 1 for plantar flexion without toe flexion, 2 when no plantar flexion could be achieved and 3 when the mouse dragged the limb (Lejay et al., 2014). Clinical scores were assessed at Day 0, 4, 6, 10, 20, and 30 for all animals by an independent evaluator.
Ex vivo Muscle Analysis
All animals were sacrificed at Day 30. Ischemic and contralateral gastrocnemius muscles were collected. The activity of mitochondrial respiration chain complexes, calcium retention capacity and production of free radicals were immediately assessed. Tibialis muscles were immersed in liquid nitrogen and stored at −80°C, for subsequent histological and RNA transcripts analysis.
Mitochondrial Respiratory Chain Complex Activities
Mitochondrial respiratory chain involves four complexes producing energy by electron transfers and oxygen consumption. In order to study the activity of mitochondrial respiratory chain complexes the consumption of oxygen in skinned skeletal muscle fibers is measured. This allows for a reliable assessment of the functional oxidative capacity (Charles et al., 2011, 2017; Mansour et al., 2012; Talha et al., 2012). Oxygen consumption is measured with Clark electrodes (Strathkelvin Instruments®, United Kingdom). A difference of potential of 0.6–0.7 mV is applied between the anode (silver electrode) and the cathode (platinum electrode), both immersed in a KCl solution. The intensity of the induced current, a recordable signal, is related to the conductance between both electrodes via the KCl bridge and is directly proportional to the oxygen consumption from the medium. Slopes of the signal, which are also measured, reflects the rate of oxygen consumption (V0). After V0 determination, substrates were added in order to specifically activate or inhibit the respiratory complexes. ADP (2 mM) and Succinate (25 mM) are then added to study complexes I, II, III, and IV activity, which determines the maximal oxidative capacity: Vmax. The addition of Amytal (0.02 mM) subsequently inhibits complex I, allowing determining Vamytal (complexes II, III, and IV activities). The addition of N, N, N′, N′-tetramethyl-p-phenylenediamine dihydrochloride (TMPD 0.5 mM) and ascorbate (0.5 mM) specifically activates complex IV (Vtmpd; Charles et al., 2011; Mansour et al., 2012).
Calcium Retention Capacity
Calcium retention capacity of fibers from gastrocnemius muscle fibers is measured by spectrofluorometry. This capacity is defined as the high cut-off amount of calcium that determines the opening of the mitochondrial transition pore, which allows the release of calcium that will in turn lead to apoptosis. Calcium pulses (20 μM) were applied to skinned fibers of gastrocnemius muscle. The mitochondrial calcium uptake was thereafter assessed after the addition of a single calcium pulse (20 μM), by measuring the decrease of the extramitochondrial calcium concentration. The measure was monitored using a fluorescent probe (Calcium Green-5N, Invitrogen). When mitochondrial calcium release started, that is when the calcium uptake showed an inflection point, it was considered that mPTP opening was observed. Mitochondrial calcium retention capacity, which is a reliable index of mPTP sensitivity, was calculated as the total amount of calcium taken up by mitochondria before calcium release.
Production of Reactive Oxygen Species Using Electron Paramagnetic Resonance
Gastrocnemius muscles (1 mm3 fragments) were incubated with a 200 μM CMH molecular probe (1-hydroxy-3-methoxycarbonyl-2, 2, 5, 5-tetramethylpyrrolidine HCl), which is oxidized in the presence of unpaired electrons of ROS. The amount of oxidized CMH, and thus the related amount of free radicals produced, was measured by the intensity of the resonance signal (Noxygen®, Allemagne).
Histological Analysis: Muscle Structure and ROS Production
Tibialis muscles were immersed in liquid nitrogen and stored at −80°C. Muscles were embedded in paraffin. A cryostat microtome was then used in order to obtain 10 mm thick sections which were mounted onto glass slides. Hematoxylin and eosin stain was applied to the specimens which were examined under bright-field microscopy. Specimens were also incubated with 2.5 mM dihydroethidium (DHE), which produces red fluorescence when oxidized to ethidium bromide (mainly by superoxide anion). After staining, sections were examined under epifluorescence microscope (Nikon Eclipse E800) and emission signals recorded.
RNA Transcripts Encoding for Mitochondrial Biogenesis and Antioxidant Defense
Tibialis muscles were immersed in liquid nitrogen and stored at −80°C. Transcripts encoding antioxidative enzymes (SOD1, SOD2, catalase) and proteins involved in mitochondrial function (PGC1α, ß, and NRF1) were analyzed. Two micrograms of RNA, isolated with TRIzol Reagent (Invitrogen), were converted to cDNA with SuperScript II reverse transcriptase (Invitrogen, Life Technologies) and hexamer primers according to the supplier's protocol. Quantitative RT-PCR was performed using the QuantiTectTM SYBR Green PCR kit (Roche) according to the supplier's protocol. Primers were for Sod1, 5′-CCAGTGCAGGACCTCATTTT-3′ (sense) and 5′-TTGTTTCTCATGGACCACCA-3′ (antisense); for Sod2, 5′-ACCCAAAGTCACGCTTGATAG-3′ (sense) and 5′-GGACAAACCTGAGCCCTAAG-3′ (antisense); for Catalase, 5′-CACTGACGAGATGGCACACT-3′ (sense) and 5′-TGTGGAGAATCGAACGGCAA-3′ (antisense); for Pgc-1α, 5′-AAGTGTGGAACTCTCTGGAACTG-3′ (sense) and 5′-GGGTTATCTTGGTTGGCTTTATG-3′ (antisense); for Pgc-1β, 5′-TGCGGAGACACAGATGAAGA-3′ (sense) and 5′-GGCTTGTATGGAGGTGTGGT-3′ (antisense); for Nrf-1, 5′-TGGAGTCCAAGATGCTAATG-3′ (sense) and 5′-AGAGCTCCATGCTACTGTTC-3′ (antisense).
Statistical analysis was performed with GraphPad Prism 5® (GraphPad Software, Inc.) under the supervision of the Department of Statistics of our university. Clinical follow-up scores of groups were compared using t-tests. Other parameters were compared using a one-way ANOVA design.
Results are expressed as means and standard deviations. p < 0.05 were considered as indicative of statistical significance.
Functional and Muscular Effects Of Chronic Limb Ischemia
In vivo Clinical Follow Up
At Day 30, among the 10 mice in the non-exercised group, ischemic limb showed auto-amputation of a toe in two mice, toe necrosis in seven mice and toe cyanosis in one mouse. Mean tissue damage score increased progressively from Day 4 to Day 30 with scores of 3.6, 3.8, 3.9, 4.0, and 4.1 at Days 4, 6, 10, 20, and 30, respectively. Concerning limb function, 8 mice dragged the ischemic limb and 2 could not achieve plantar flexion at Day 30. Mean functional damage score increased progressively from Day 4 to Day 30 with scores of 2.0, 2.6, 2.7, 2.8, and 2.8 at Days 4, 6, 10, 20, and 30, respectively (Figure 1). Contralateral limbs showed no tissue or functional damage.
Figure 1. Exercise improved tissue damage and functional scores in the exercised group compared to the non-exercised group. Tissue damage (A) and functional (B) scores were evaluated in non-exercised (n = 10) and exercised (n = 10) groups. Results are expressed as means and standard deviations at days 0, 4, 6, 10, 20, and 30. *p < 0.05; **p < 0.01.
In agreement with previous results (Lejay et al., 2015), hematoxylin eosin staining showed typical myopathic features of ischemic muscles, with wider range in fiber size, a more rounded shape, centrally located nuclei, and smaller cross-sectional areas compared to control fibers (Figure 2).
Figure 2. Exercise allowed the recovery of the myopathic feature. Tibialis muscles specimens were examined under bright-field microscopy after hematoxylin-eosin stain (x40). Hematoxylin eosin showed myopathic features of ischemic muscles in the non-exercised group (A Control limb, B Ischemic limb), exercise does not (C Control limb + exercise, D Ischemic limb + exercise).
Mitochondrial respiration was decreased in chronic ischemic muscles. V0 was 3.47 ± 0.24 mmol 02/min/g dry weight (dw) in control limb and 2.39 ± 0.19 mmol 02/min/g dw in ischemic limb (p < 0.001). The same applied to Vmax (9.86 ± 0.86 in control limb vs. 7.11 ± 1.14 mmol 02/min/g dw in ischemic limb, p < 0.001); Vamytal (6.35 ± 0.79 in control limb vs. 4.44 ± 0.62 mmol 02/min/g dw in ischemic limb, p < 0.001); and Vtmpd (10.62 ± 0.76 in control limb vs. 8.49 ± 1.25 mmol 02/min/g dw in ischemic limb, p < 0.001; Figure 3).
Figure 3. Mitochondrial respiration is restored in ischemic limbs after exercise. V0 = Basal mitochondrial oxidative capacity; Vmax = Maximal mitochondrial oxidative capacity; Vamytal = Complexes II, III, and IV activity; Vtmpd = Complexes IV activity. Mean ± SD at Day 30 in the non-exercised group (n = 10) and in the exercised group (n = 10). **p < 0.01; ***p < 0.001.
Calcium retention capacity was impaired in ischemic limbs: 11.96 ± 0.92 in control limbs vs. 7.01 ± 0.97 μM/mg dw in ischemic limbs (p < 0.001; Figure 4).
Figure 4. Calcium retention capacity is restored in ischemic limbs after exercise. Mean ± SD at Day 30 in the non-exercised group (n = 10) and in the exercised group (n = 10). ***p < 0.001.
Production of free radicals was significantly increased in ischemic muscles (0.11 ± 0.02 mmol/min/mg dw) compared to control limbs (0.07 ± 0.02 mmol/min/mg dw; p < 0.05; Figure 5A). DHE staining showed higher fluorescence in ischemic limbs compared to control limbs (Figure 5B).
Figure 5. Oxidative stress is increased by critical limb ischemia and exercise. Production of free radicals (A) was increased in ischemic muscles (n = 10) compared to control muscles (n = 10) in the non-exercised group. DHE staining (B) showed higher fluorescence in ischemic muscles compared to control muscles (a, Control limb; b, Ischemic limb) in the non-exercised group. Production of free radicals was increased in the exercised group compared to the non-exercised group (A). Exercice showed higher fluorescence (B) in control and ischemic limbs (c, Control limb + exercise; d, Ischemic limb + exercise). *p < 0.05; **p < 0.01.
Finally, ischemia decreased mRNA expression of antioxidant enzymes (0.39 ± 0.10 vs. 0.10 ± 0.06 for SOD1 (p < 0.05), 0.32 ± 0.16 vs. 0.11 ± 0.07 for SOD2 (p < 0.05) and 0.38 ± 0.04 vs. 0.22 ± 0.11 for catalase (p < 0.05) in control and ischemic muscles respectively; Figure 6A). Ischemia also decreased the relative mRNA expression of mitochondrial function markers (0.90 ± 0.29 vs. 0.52 ± 0.39 for PGC1α (p < 0.05), 0.87 ± 0.41 vs. 0.68 ± 0.39 for PGC1β (p < 0.05) and 0.34 ± 0.14 vs. 0.24 ± 0.13 for NRF1 (p < 0.05) in control and ischemic muscles respectively; Figure 6B).
Figure 6. Relative mRNA expression of anti-oxidant and mitochondrial function markers are increased after exercise. Mean ± SD at Day 30 in the non-exercised group (n = 4) and in the exercised group (n = 5). *p < 0.05; **p < 0.01; ***p < 0.001. (SOD, superoxide dismutase; PGC, proliferator activated receptor gamma coactivator; NRF, nuclear respiratory factor).
The Deleterious Effects of Chronic Limb Ischemia Are Attenuated by Moderate Exercise
In vivo Clinical Follow Up
After ischemia, among the 10 mice in exercised group, one mouse presented with toe cyanosis, seven mice had a white aspect of the limb, and two mice had a normal aspect of the limb at Day 30. Mean tissue damage decreased after exercise initiation from Day 4 to Day 30 with scores of 3.5, 3.7, 3.0, 2.4, and 1.9 at Days 4, 6, 10, 20, and 30, respectively. Tissue damage was significantly decreased in exercised group compared to non-exercised group.
At Day 30, four mice could not achieve plantar flexion, and six mice could not achieve toe flexion. Mean functional damage score decreased after exercise initiation from Day 4 to Day 30 with scores of 1.9, 2.5, 2.0, 1.7, and 1.4 at Days 4, 6, 10, 20, and 30, respectively (Figure 1). Functional damage was significantly decreased in exercised group compared to non-exercised group.
Contralateral Limbs Showed No Tissue or Functional Damage
Unlike muscles without exercise, exercised ischemic muscles did not exhibit myopathic features (Figure 2).
Mitochondrial respiration was restored in ischemic muscles, since it was not significantly different in control limbs as compared to ischemic limbs (V0 was 3.52 ± 0.42 vs. 3.73 ± 0.90 mmol O2/min/g dw, Vmax was 9.82 ± 0.68 vs. 9.75 ± 1.00 mmol O2/min/g dw, Vamytal was 5.94 ± 0.62 vs. 6.02 ± 0.90 mmol O2/min/g dw, and Vtmpd was 9.90 ± 1.04 vs. 9.46 ± 0.95 mmol O2/min/g dw in control and ischemic limbs respectively; Figure 3).
Calcium retention capacity was restored in ischemic muscles: 12.01 ± 1.24 in control exercised limbs vs. 11.36 ± 1.33 μM/mg dw in ischemic exercised limbs (Figure 4).
Free radicals production showed no significant difference between control exercised muscles and ischemic exercised muscles: 0.11 ± 0.03 vs. 0.13 ± 0.04 mmol/min/mg dw respectively (Figure 5A). DHE staining exhibited a significantly higher fluorescence in exercised muscles compared to non-exercised muscles, even in control limbs (Figure 5B).
Exercise increased significantly mRNA levels of anti-oxidant enzymes in control muscles [0.39 ± 0.10 vs. 3.62 ± 1.89 for SOD1 (p < 0.001), 0.32 ± 0.16 vs. 2.90 ± 0.84 for SOD2 (p < 0.001) and 0.39 ± 0.16 vs. 1.61 ± 0.49 for catalase (p < 0.05) in non-exercised and exercised muscles respectively]. Exercise also increased significantly the transcripts of anti-oxidant enzymes in ischemic muscles (0.10 ± 0.06 vs. 1.73 ± 1.03 for SOD1 (p < 0.01), 0.11 ± 0.07 vs. 1.33 ± 1.01 for SOD2 (p < 0.01) and 0.22 ± 0.11 vs. 1.29 ± 1.18 for catalase (p < 0.05) in non-exercised and exercised muscles respectively; Figure 6A).
Exercise also increased significantly mRNA levels of mitochondrial function markers in control muscles [0.90 ± 0.29 vs. 0.52 ± 0.39 for PGC1α (p < 0.05), 0.87 ± 0.41 vs. 1.81 ± 0.31 for PGC1β (p < 0.001), and 0.34 ± 0.14 vs. 0.74 ± 0.19 for NRF1 (p < 0.05) in non-exercised and exercised muscles respectively], as well as in ischemic muscles [0.52 ± 0.39 vs. 0.93 ± 0.42 for PGC1α (p < 0.01), 0.68 ± 0.39 vs. 1.79 ± 0.83 for PGC1β (p < 0.01) and 0.24 ± 0.13 vs. 0.66 ± 0.34 for NRF1 (p < 0.05; Figure 6B)]. Thus, even though PGC1α, PGC1β, NRF1, SOD1, SOD2, and catalase transcript levels were lower in ischemic limb muscles than in control muscles of non-exercised mice, they were similar or higher in exercised ischemic limb muscle than in non-exercised control limb.
The key findings of this study are that moderate exercise, which slightly increases oxidative stress, might allow for shorter time for limb recovery, probably by restoring functional capacities, mitochondrial function and calcium retention capacity in the setting of CLI. It is likely that exercise induces an increased mitochondrial biogenesis, as well as antioxidant capacities in skeletal muscles, which may involve ROS signaling. To our knowledge, this is the first study suggesting the beneficial role of low-intensity exercise in the setting of CLI.
Chronic Critical Limb Ischemia Characteristics
This model fulfills all criteria defining CLI, since the use of sequential artery ligations induces chronic hypoperfusion (confirmed by scintigraphies) responsible for clinical and functional symptoms lasting for more than 2 weeks (Norgren et al., 2007; Lejay et al., 2015). Previous models of lower limb ischemia are mostly based on a single arterial ligation, mainly a femoral artery (just distal to the origin of the profunda femoris) ligation (Lofti et al., 2013). However, this method leaves most of the collateral circulation to the lower limb intact, and consequently, blood flow to the limb is always restored within 7 days. Another surgical model is based on a total excision of the femoral artery, including the collateral vessels. However, blood flow is restored progressively. This can be explained since the collateral bed mostly arises from the internal iliac artery (Lofti et al., 2013). In our CLI model, we performed sequential ligations. This allowed us to obtain a sustainable hypoperfusion, likely because the second ligation was performed on the common iliac artery and reduced the collateral perfusion provided by the internal iliac artery (Lejay et al., 2015). Moreover, even if ligation of the blood flow of one limb might produce hormonal changes systematically, we already showed that contralateral limb can be considered a control (Lejay et al., 2015).
Beneficial Effects of Moderate Exercise in Chronic Critical Limb Ischemia
Preclinical or clinical studies examining the effect of exercise in the setting of intermittent claudication are numerous (Gardner et al., 2008; Abe et al., 2012; Haas et al., 2012; Muller-Buhl et al., 2012; Hoier et al., 2013), but few data are available in the setting of CLI, despite its increasing occurrence and morbidity (Olin et al., 2016). Thus, outcomes are worse in patients with CLI: at 1 year, 10% of them will undergo a deadly cardiovascular event, and 25% of them will require leg or thigh amputation (Norgren et al., 2007; Olin et al., 2016).
Exercise therapy is proposed in first intention for patients presenting with infrainguinal lesions and intermittent claudication (Norgren et al., 2007; Daussin et al., 2008; Da Silva et al., 2015; Baum et al., 2016), but, since CLI patients can be physically limited and thus restricted in terms of walking capacities or exercise tolerance, such a therapy is currently not used (Muller-Buhl et al., 2012; Baum et al., 2016; Olin et al., 2016). We therefore specifically aimed at studying the effects of a moderate-intensity training protocol.
Our data demonstrate that moderate-intensity exercise training reduces significantly tissue damages. Indeed, confirming the functional improvement observed after exercise, HE staining highlights the fact that the CLI-related myopathic features disappear after training.
Further analyzing skeletal muscle integrity, we also observed a normalization of the mitochondrial respiration; all complexes of the mitochondrial respiratory chain showing increased oxidative capacities. This is a key result since, besides reduced oxygen supply, mitochondrial dysfunction participates in CLI pathophysiology (Dopheide et al., 2013; Lejay et al., 2014, 2015; Chen et al., 2016) and accordingly, improvement in muscle mitochondrial function has been shown to be associated with improved prognosis in PAD patients (Pedersen et al., 2009).
In addition, we observed that moderate exercise restored the mitochondrial calcium retention capacity, delaying mPTP opening and therefore likely apoptosis. Indeed, the mPTP is a non-selective channel located through the inner mitochondrial membrane which is predominantly in a closed state during physiological conditions. A major consequence of mPTP opening is dissipation of the proton electrochemical gradient, leading to the inhibition of ATP production and finally, mitochondrial swelling, and rupture, initiating the apoptotic processes (Tran et al., 2012; Pottecher et al., 2013; Garbaisz et al., 2014). Some experimental studies examined the effect of acute lower-limb ischemia-reperfusion on mPTP (Tran et al., 2012; Pottecher et al., 2013; Garbaisz et al., 2014), but this is the first work investigating the potential modulating effect of exercise on mPTP opening during CLI.
Interestingly, moderate exercise delays mPTP opening, mitigating therefore CLI damages, and favoring increased functional abilities. This highlights the potential of exercise therapy in CLI, particularly knowing that improved exercise performance generally results in quality of life improvement and thus better prognosis.
Exercise could be achieved despite flow limitation and mitochondrial function impairment. Indeed, one might suggest that strong flow limitation should be associated with “no” exercise capacity. In fact, although significant, mitochondrial impairment is relatively moderate and our model induces hypoperfusion rather than complete ischemia. Additionally, muscle susceptibility to ischemia reperfusion depends on their metabolic phenotype and thus some muscles—mainly oxidative—might be less impaired (Charles et al., 2017). Compensation by other muscles that are not or only slightly impaired by ischemia reperfusion might play a role in the degree of functional impairment observed after ischemia reperfusion injury.
Mechanisms Likely Involved in Exercise-Related Improvements
We aimed to challenge the hypothesis that ROS signaling might participate in muscle protection through mitochondrial functions and anti-oxidative pathways enhancement. Although, ROS production is thought to be a key event during ischemia-reperfusion-induced deleterious effects, its kinetic is poorly studied and particularly, whether there is ROS production during ischemia remains a debated question (Paradis et al., 2016). Indeed, lack of oxygen availability during ischemia should preclude ROS formation, and models that report ROS production in ischemia may take oxygen from the room air. However, we previously demonstrated that ROS generation occurs during ischemia (Guillot et al., 2014). Several hypotheses might be proposed. First, hypoxia might not be total because of residual O2 levels in the tissues. Additionally, our CLI model does not induce complete ischemia, but rather hypoperfusion and therefore hypoxemia. Finally, a reduced antioxidant defense secondary to ischemia might explain an increased ROS level during ischemia even if production is only slightly enhanced.
It has been demonstrated that exercise induces ROS production in skeletal muscle (Sakellariou et al., 2014; Merry and Ristow, 2016). The conjunction of CLI-induced ROS production and exercise-induced ROS production might favor mitochondrial dysfunction. However, exercise might contribute to ameliorate mitochondrial function despite increased oxidative stress, if ROS production is low enough to result in a positive biological signal, so called “mitohormesis.” Hormesis is a process whereby exposure to low stress level promotes adaptive changes allowing the cell to better tolerate subsequent greater stress (Bouitbir et al., 2012; Lejay et al., 2014; Merry and Ristow, 2016). Strong evidence suggests that mitochondria allow the initiation and transduction of a signal to the nucleus, resulting in a transcriptional response with both mitochondrial and non-mitochondrial adaptations, maintaining cellular homeostasis (Ji et al., 2006, 2016).
Our results suggest that ROS signaling is, at least in part, responsible for mediating exercise-induced increases in mitohormesis within skeletal muscle, as well as antioxidant capacity (He et al., 2016; Ji et al., 2016; Merry and Ristow, 2016). Indeed, although excessive ROS production is damaging the cardiovascular system, small amounts of ROS are beneficial for adaptive processes following ischemia (Ebrahimian et al., 2006; Haas et al., 2012). Particularly, ROS have been shown to play the role of important cell signaling molecules when analyzing beneficial exercise-induced adaptations to skeletal muscle (Irrcher et al., 2009). Accordingly, exercise is much less beneficial when exercise-induced ROS cell signaling is decreased, either by enzymatic inhibitors or antioxidant supplementation (Ljubicic et al., 2010; Higashida et al., 2011; Meier et al., 2013; Wadley et al., 2013; Strobel et al., 2014; He et al., 2016; Ji et al., 2016; Merry and Ristow, 2016; Boveris and Navarro, 2008). In our study, we postulate that mitohormesis and activation of the antioxidant machinery might be contributing to the signaling of exercise-related adaptation in CLI.
Accordingly, exercise increases the expression of PGC1-α and NRF1. PGC1-α is considered as one of the most important regulator of mitohormesis. Specifically in skeletal muscle, a large body of evidence suggests that PGC1-α regulates mitochondrial function, mitochondrial respiration and biogenesis. In particular, PGC1-α interacts with NRF-1 to activate genes involved in the respiratory chain and to stimulate mitochondrial biogenesis (Ljubicic et al., 2010).
Similarly, PGC1-β was shown to promote the expression of genes involved in mitochondrial structure and function, but also to be significantly involved in anti-oxidant defense (Charles et al., 2013; Gali Ramamoorthy et al., 2015; Lee et al., 2016). Further, decreased PGC1-β levels in aged muscle correlates with mitochondrial function decline (Charles et al., 2013). In our study, exercise increased mRNA expression of PGC1-β and anti-oxidant enzymes SOD-1, SOD-2 and catalase, suggesting that the beneficial effect of moderate exercise might be, at least partly, related to muscle antioxidant capacity enhancement.
This study presents several limitations. Clearly, moderate exercise promotes recovery of the ischemic limb in CLI, but experiments of contraction strength would have been useful to further assess muscle function. Moreover, our data do not allow differentiating between increased mitochondrial number and/or capacities. Finally, further studies at the protein levels should further reinforce the implication of mitochondria and ROS in the mechanisms involved.
In conclusion, moderate exercise training in CLI provides beneficial effects allowing accelerated limb recovery. Mechanisms involved in this protective effect could be activation of antioxidant defenses and mitohormesis, supporting that moderate exercise should be taken into account as a potential therapeutic option in patients with CLI.
AL: Study design, data collection, data analysis, writing. GL, SD: Data analysis. SP, AS, FS, EL, VW: Writing. AC: Data collection, data analysis. JZ: Study design, data collection. FT, FF: Study design. DM: Data analysis, writing. NC: Study design, writing. BG: Study design, data analysis, writing.
This work has been supported by a grant from the French Society of Vascular Surgery.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
We thank Isabelle Bentz and Fabienne Goupilleau for their technical assistance. We thank Michael Schaeffer for his help in the statistical analysis.
Abe, T., Loenneke, J. P., Fahs, C. A., Rossow, L. M., Thiebaud, R. S., and Bemben, M. G. (2012). Exercise intensity and muscle hypertrophy in blood-flow restricted limbs and non-restricted muscles: a brief review. Clin. Physiol. Funct. Imaging 32, 247–252. doi: 10.1111/j.1475-097X.2012.01126.x
Baum, O., Torchetti, E., Malik, C., Hoier, B., Walker, M., Walker, P. J., et al. (2016). Capillary ultrastructure and mitochondrial density in skeletal muscle in relation to reduced exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol. 310, 943–952. doi: 10.1152/ajpregu.00480.2015
Bouitbir, J., Charles, A. L., Echaniz-Laguna, A., Kindo, M., Daussin, F., Auwerx, J., et al. (2012). Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a ‘mitohormesis’ mechanism involving reactive oxygen species and PGC-1. Eur. Heart J. 33, 1397–1407. doi: 10.1093/eurheartj/ehr224
Charles, A. L., Guilbert, A. S., Bouitbir, J., Goette-Di Marco, P., Enache, I., Zoll, J., et al. (2011). Effect of postconditioning on mitochondrial dysfunction in experimental aortic cross-clamping. Br. J. Surg. 98, 511–516. doi: 10.1002/bjs.7384
Charles, A. L., Guilbert, A. S., Guillot, M., Talha, S., Lejay, A., Meyer, A., et al. (2017). Muscles susceptibility to ischemia-reperfusion injuries depends on fiber type specific antioxidant level. Front. Physiol. 8:52. doi: 10.3389/fphys.2017.00052
Charles, A. L., Meyer, A., Dal-Ros, S., Auger, C., Keller, N., Ramamoorthy, T. G., et al. (2013). Polyphenols prevent ageing-related impairment in skeletal muscle mitochondrial function through decreased reactive oxygen species production. Exp. Physiol. 98, 536–545. doi: 10.1113/expphysiol.2012.067496
Chen, X., An, X., Chen, D., Ye, M., Shen, W., Han, W., et al. (2016). Chronic exercise training improved aortic endothelial and mitochondrial function via an AMPKα2-dependent manner. Front. Physiol. 7:631. doi: 10.3389/fphys.2016.00631
Conte, M. S., and Pomposelli, F. B. (2015). Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J. Vasc. Surg. 61, 1S. doi: 10.1016/j.jvs.2014.12.006
Da Silva, N. D. Jr., Roseguini, B. T., Chehuen, M., Fernandes, T., Mota, G. F., Martin, P. K., et al. (2015). Effects on oral N-acetylcysteine on walking capacity, leg reactive hyperemia, and inflammatory and angiogenic mediators in patients with intermittent claudication. Am. J. Physiol. Heart. Circ. Physiol. 309, H897–H905. doi: 10.1152/ajpheart.00158.2015
Daussin, F. N., Zoll, J., Ponsot, E., Dufour, S. P., Doutreleau, S., Lonsdorfer, E., et al. (2008). Training at high exercise intensity promotes qualitative adaptations of mitochondrial function in human skeletal muscle. J. Appl. Physiol. 104, 1436–1441. doi: 10.1152/japplphysiol.01135.2007
Dopheide, J. F., Doppler, C., Scheer, M., Obst, V., Radmacher, M. C., Radsak, M. P., et al. (2013). Critical limb ischaemia is characterized by an increased production of whole blood reactive oxygen species and expression of TREM-1 neutrophils. Atherosclerosis 229, 396–483. doi: 10.1016/j.atherosclerosis.2013.05.029
Ebrahimian, T. G., Heymes, C., You, D., Blanc-Brude, O., Mees, B., Waeckel, L., et al. (2006). NADPH oxidase-derived overproduction of reactive oxygen species impairs postoschemic neovascularization in mice. Am. J. Pathol. 169, 719–728. doi: 10.2353/ajpath.2006.060042
Gali Ramamoorthy, T., Laverny, G., Schlagowski, A. I., Zoll, J., Messaddeq, N., Bornert, J. M., et al. (2015). The transcriptional coregulator, PGC-1β controls mitochondrial function and anti-oxidant defence in skeletal muscles. Nat. Commun. 6:10210. doi: 10.1038/ncomms10210
Garbaisz, D., Turoczi, Z., Aranyi, P., Fulop, A., Rosero, O., Hermesz, E., et al. (2014). Attenuation of skeletal muscle and renal injury to the lower limb following ischemia-reperfusion using mPTP inhibitor NIM-811. PLoS ONE 9:e101067. doi: 10.1371/journal.pone.0101067
Gardner, A. W. (2015). Exercise rehabilitation for peripheral arterial disease: an exercise physiology perspective with special emphasis on the emerging trend of home-based exercise. VASA 44, 405–417. doi: 10.1024/0301-1526/a000464
Gardner, A. W., Montgomery, P. S., and Parker, D. E. (2008). Physical activity is a predictor of all-cause mortality in patients with intermittent claudication. J. Vasc. Surg. 47, 117–122. doi: 10.1016/j.jvs.2007.09.033
Guillot, M., Charles, A. L., Chamaraux-tran, T. N., Bouitbir, J., Meyer, A., Zoll, J., et al. (2014). Oxidative stress precedes skeletal muscle mitochondrial dysfunction during experimental aortic cross-clamping but is not associated with early lung, herat, brain, liver, or kidney mitochondrial impairment. J. Vasc. Surg. 60, 1043–1051. doi: 10.1016/j.jvs.2013.07.100
Higashida, K., Kim, S. H., Higuchi, M., Holloszy, J. O., and Han, D. H. (2011). Normal adaptations to exercise despite protection against oxidative stress. Am. J. Physiol. Endocrinol. 301, 779–784. doi: 10.1152/ajpendo.00655.2010
Hoier, B., Walker, M., Passos, M., Walker, P. J., Green, A., Bangsbo, J., et al. (2013). Angiogenic response to passive movement and active exercise in individuals with peripheral arterial disease. J. Appl. Physiol. 115, 1777–1787. doi: 10.1152/japplphysiol.00979.2013
Irrcher, I., Ljubicic, V., Kirwan, A., Walker, P. J., Green, A., Bangsbo, J., et al. (2009). Interactions between ROS and AMP kinase activity in the regulation of PGC-1alpha transcription in skeletal muscle cells. Am. J. Physiol. Cell Physiol. 296, 116–123. doi: 10.1152/ajpcell.00267.2007
Lee, D. E., Brown, J. L., Rosa, M. E., Brown, L. A., Perry, R. A., Washington, T. A., et al. (2016). Translational machinery of mitochondrial mRNA is promoted by physical activity in Western diet-induced obese rats. Acta Physiol. 218, 167–177. doi: 10.1111/apha.12687
Leeper, N. J., Myers, J., Zhou, M., Nead, K. T., Syed, A., Kojima, Y., et al. (2013). Exercise capacity is the strongest predictor of mortality in patients with peripheral arterial disease. J. Vasc. Surg. 5, 728–733. doi: 10.1016/j.jvs.2012.07.051
Lejay, A., Choquet, P., Thaveau, F., Singh, F., Schlagoswski, A., Charles, A. L., et al. (2015). A murine model of sustainable and durable critical limb ischemia. Eur. J. Vasc. Endovasc. Surg. 49, 205–212. doi: 10.1016/j.ejvs.2014.12.010
Lejay, A., Meyer, A., Schlagowski, A. I., Charles, A. L., Singh, F., Bouitbir, J., et al. (2014). Mitochondrial participation to ischemia-reperfusion injury in skeletal muscle. Int. J. Biochem. Cell. 50, 101–105. doi: 10.1016/j.biocel.2014.02.013
Ljubicic, V., Joseph, A. M., Saleem, A., Uguccioni, G., Collu-Marchese, M., Lai, R. Y., et al. (2010). Transcriptional and post-transcriptional regulation of mitochondrial biogenesis in skeletal muscle: effects of exercise and aging. Biochim. Biophys. Acta. 1800, 223–224. doi: 10.1016/j.bbagen.2009.07.031
Lofti, S., Patel, A. S., Mattock, K., Eggington, S., Smith, A., and Modarai, B. (2013). Towards a more relevant hind limb model of muscle ischaemia. Atherosclerosis 227, 1–8. doi: 10.1016/j.atherosclerosis.2012.10.060
Mahoney, E. M., Wang, K., Keo, H. H., Duval, S., Smolderen, K. G., Cohen, D. J., et al. (2010). Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States. Circ. Cardiovasc. Qual. Outcomes 3, 642–651. doi: 10.1161/CIRCOUTCOMES.109.930735
Mansour, Z., Boutibir, J., Charles, A. L., Talha, S., Kindo, M., Pottecher, J., et al. (2012). Remote and local ischemic preconditioning equivalently protects rat skeletal muscle mitochondrial function during experimental aortic cross-clamping. J. Vasc. Surg. 55, 497–505. doi: 10.1016/j.jvs.2011.07.084
Meier, P., Renga, M., Hoppeler, H., and Baum, O. (2013). The impact of antioxidant supplements and endurance exercise on genes of the carbodydrate and lipid metabolism in skeletal muscle of mice. Cell Biochem. Funct. 31, 51–59. doi: 10.1002/cbf.2859
Muller-Buhl, U., Engeser, P., Leutgeb, R., and Szecsenyi, J. (2012). Eligibility of patients with peripheral arterial disease for participation in a community-based walking exercise program: a single-centre experience. Int. Angiol. 31, 462–467.
Norgren, L., Hiatt, W. R., and Dormandy, J. A. (2007). TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur. J. Vasc. Endovasc. Surg. 33, S1–S75. doi: 10.1016/j.ejvs.2006.09.024
Nunomiya, A., Shin, J., Kitajima, Y., Dan, T., Miyata, T., and Nagatomi, R. (2016). Activation of the hypoxia-inducible factor pathway induced by prolyl hydroxylase domain 2 deficiency enhances the effect of running training in mice. Acta. Physiol. 8:2. doi: 10.1111/apha.12751
Olin, J. W., White, C. J., Armstrong, E. J., Kadian-Dodov, D., and Hiatt, W. R. (2016). Peripheral artery disease, evolving role of exercise, medical therapy, and endovascular options. J. Am. Coll. Cardiol. 67, 1338–1357. doi: 10.1016/j.jacc.2015.12.049
Paradis, S., Charles, A. L., Meyer, A., Lejay, A., Scholey, J. W., Chakfé, N., et al. (2016). Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion. Am. J. Physiol. Cell Physiol. 310, C968–C982. doi: 10.1152/ajpcell.00356.2015
Parmenter, B. J., Dieberg, G., and Smart, N. A. (2015). Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis. Sports Med. 45, 231–244. doi: 10.1007/s40279-014-0261-z
Pedersen, B. L., Baekgaard, N., and Quistorff, B. (2009). Mitochondrial function in patients with type 2 diabetes mellitus and peripheral arterial disease: implications in vascular surgery. J. Vasc. Endovasc. Surg. 38, 356–364. doi: 10.1016/j.ejvs.2009.04.014
Pottecher, J., Guillot, M., Belaidi, E., Charles, A. L., Lejay, A., Gharib, A., et al. (2013). Cyclosporine A normalizes mitochondrial coupling, reactive oxygen species production, and inflammation and partially restores skeletal muscle maximal oxidative capacity in experimental aortic cross-clamping. J. Vasc. Surg. 57, 1100–1108. doi: 10.1016/j.jvs.2012.09.020
Rokutanda, T., Izumiya, Y., Miura, M., Fuduka, S., Shimada, K., Izumi, Y., et al. (2011). Passive exercise using whole-body periodic acceleration enhances blood supply to ischemic hindlimb. Arterioscler. Thromb. Vasc. Biol. 31, 2872–2880. doi: 10.1161/ATVBAHA.111.229773
Ryan, T. E., Schmidt, C. A., Green, T. D., Brown, D. A., Neufer, P. D., and McClung, J. M. (2015). Mitochondrial regulation of the muscle microenvironment in critical limb ischemia. Front. Physiol. 6:336. doi: 10.3389/fphys.2015.00336
Sakellariou, G. K., Jackson, M. J., and Vasilaki, A. (2014). Redefining the major contributors to superoxide production in contracting skeletal muscle. The role of NADPH oxidases. Free. Radic. Res. 48, 12–29. doi: 10.3109/10715762.2013.830718
Shishehbor, M. H., White, C. J., Gray, B. H., Menard, M. T., Lookstein, R., Rosenfield, K., et al. (2016). Critical limb ischemia: an expert statement. J. Am. Coll. Cardiol. 68, 2002–2015. doi: 10.1016/j.jacc.2016.04.071
Stabile, E., Burnett, M. S., Watkins, C., Kinnaird, T., Bachis, A., la Sala, A., et al. (2003). Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation 108, 205–210. doi: 10.1161/01.CIR.0000079225.50817.71
Strobel, N. A., Matsumoto, A., Peake, J. M., Marsh, S. A., Peternelj, T. T., Briskey, D., et al. (2014). Altering the redox state of skeletal muscle by glutathione depletion increases the exercise-activation of PGC-1α. Physiol. Rep. 2:12224. doi: 10.14814/phy2.12224
Talha, S., Boutibir, J., Charles, A. L., Zoll, J., Goette-Di Marco, P., Meziani, F., et al. (2012). Pretreatment with brain natriuretic peptide reduces skeletal muscle mitochondrial dysfunction and oxidative stress after ischemia-reperfusion. J. Appl. Physiol. 15:114. doi: 10.1152/japplphysiol.00239.2012
Thaveau, F., Zoll, J., Bouitbir, J., Ribera, F., Di Marco, P., Chakfe, N., et al. (2009). Contralateral leg as a control during skeletal muscle ischemia-reperfusion. J. Surg. Res. 155, 65–69. doi: 10.1016/j.jss.2008.08.001
Thaveau, F., Zoll, J., Rouyer, O., Chakfe, N., Kretz, J. G., Piquard, F., et al. (2007). Ischemic preconditioning specifically restores complexes I and II activities of the mitochondrial respiratory chain in ischemic skeletal muscle. J. Vasc. Surg. 46, 541–547. doi: 10.1016/j.jvs.2007.04.075
Tran, T. P., Tu, H., Liu, J., Muelleman, R. L., and Li, Y. L. (2012). Mitochondria-derived superoxide links to tourniquet-induced apoptosis in mouse skeletal muscle. PLoS ONE 7:e43410. doi: 10.1371/journal.pone.0043410
Wadley, G. D., Nicolas, M. A., Hiam, D. S., and McConell, G. K. (2013). Xanthine oxidase inhibition attenuates skeletal muscle signaling following acute exercise but does not impair mitochondrial adaptations to endurance training. Am. J. Physiol. Endocrinol. Metab. 304, 853–862. doi: 10.1152/ajpendo.00568.2012
Keywords: exercise, ischemia, peripheral arterial disease, mitochondria, muscle, oxidative stress, sarcopenia
Citation: Lejay A, Laverny G, Paradis S, Schlagowski A-I, Charles A-L, Singh F, Zoll J, Thaveau F, Lonsdorfer E, Dufour S, Favret F, Wolff V, Metzger D, Chakfe N and Geny B (2017) Moderate Exercise Allows for shorter Recovery Time in Critical Limb Ischemia. Front. Physiol. 8:523. doi: 10.3389/fphys.2017.00523
Received: 24 April 2017; Accepted: 07 July 2017;
Published: 25 July 2017.
Edited by:Agustín Guerrero-Hernández, Center for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV), Mexico
Reviewed by:Pasquale Pagliaro, University of Turin, Italy
Adán Dagnino-Acosta, University of Colima, Mexico
Copyright © 2017 Lejay, Laverny, Paradis, Schlagowski, Charles, Singh, Zoll, Thaveau, Lonsdorfer, Dufour, Favret, Wolff, Metzger, Chakfe and Geny. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Anne Lejay, email@example.com